<< Back To Authors

Overview

Benjamin Ryan

Editor-at-Large for POZ and its sister publications Hep, Cancer Health and Real Health, where he covers the science of HIV, hepatitis C and cancer. He has also written for The New York Times, The Guardian, New York, The Nation, The Atlantic, The Marshall Project, The Village Voice, The New York Observer, Men's Journal, City & State, Quartz, Out and The Advocate.

Articles

Addressing Needs of Trans Women With HIV Tied to Improved Viral Suppression

A recent study found that factors such as mental health and food security were associated with higher rates of successful HIV treatment.

New Molecule Identified That May Further Suppress Effectively Treated HIV

In a recent study, the molecule delayed viral rebound in latently infected cells after antiretrovirals were discontinued.

Naloxone Prescriptions Are Up, but Still Not Nearly Enough

The drug can quickly reverse an opioid overdose and prevent death.

Aerobic Exercise Tied to Improved Depression in People With HIV

However, a recent literature review did not find a link between such exercise and improved inflammation.

Many People With HIV Who Inject Drugs Could Benefit From Risk Reduction Efforts

A CDC survey found concerning rates of high-risk sex and injection practices and a lower rate of successful treatment of HIV.

Recovering From Opioid Addiction Is Likely Harder Than From Alcoholism

The first national study of opioid use disorder recovery found that staying off such drugs often requires great effort and various services.

As Kids Born With HIV Grow Up, Adherence to Treatment Gets Hard

A long-term study sought to determine which factors help predict low adherence among young people with the virus.

Stressors Hamper Undocumented Africans’ Access to HIV Care in U.S.

Researchers interviewed undocumented African immigrants living with HIV in New York City.

Hot topics

Forums: Support and discussion

Blogs: The community speaks

POZ Stories: Get inspired

Magazine: Search the archives

HIV: The Basics

Recursos de VIH/SIDA en Español

AIDS Is Everyday

Ask POZ

For Seniors, HIV Is Tied to Higher Death Rates After Cancer Treatment

This held particularly true for prostate and breast cancers in a recent analysis.

Blood Tests Can Predict Fatty Liver Disease in Those With HIV

Researchers have identified biomarkers that can identify NAFLD and rule out advanced fibrosis.

HIV Test-and-Treat Program Would Greatly Lower HIV in Africa

The PopART study is one of three that have recently reported findings of such programs in sub-Saharan Africa.

Only Subnormal Kidney Function May Get Boost From Switch to New Tenofovir

Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.

Among Those With HIV, Hep C Is Not Linked to Heart Disease or Cancers

Researchers compared health outcomes among people with HIV, including those with and without hepatitis C.

a doctor in white jacket making a peace sign with his fingers

2-Drug Regimen Is Comparably Effective to 3-Drug Treatment

Updating previous, similar findings, researchers have now reported on 96-week data from a pair of ongoing trials.

High HIV Suppression Among Those Who Switch to Two-Drug Dovato

A late-stage trial randomized people taking a stable HIV regimen to switch to Dovato or stay on their current antiretrovirals.

WHO Endorses On-Demand PrEP for Gay and Bi Men

On-demand, or 2-1-1, PrEP requires taking only four doses of Truvada during the days surrounding sex.